Circulation, Vol 87, 562-572, Copyright © 1993 by American Heart Association
SC Krishnan and C Antzelevitch
BACKGROUND. We recently reported that sodium channel block can produce
opposite effects on action potential duration (APD) and refractoriness in
epicardial versus endocardial tissues of the canine ventricle. In addition,
strong sodium channel current inhibition was found to cause loss of the
action potential dome in epicardium but not endocardium, thus inducing a
marked dispersion of repolarization and refractoriness between epicardium
and endocardium as well as among neighboring epicardial sites. The marked
heterogeneity that evolves under these conditions provides a substrate for
the development of arrhythmias. Flecainide was found to induce
extrasystolic activity more readily than other sodium blockers. The present
study contrasts the electrophysiological actions of flecainide in canine
ventricular epicardium and endocardium and examines the characteristics of
flecainide-induced arrhythmias in epicardial sheets of canine ventricle.
METHODS AND RESULTS. Standard microelectrode techniques were used.
Flecainide (10-20 microM) produced either prolongation or marked
abbreviation of APD in epicardium but only minor changes in the APD of
endocardium. Marked abbreviation of APD in epicardium was due to loss of
the action potential dome (plateau phase). Arrhythmias displaying
characteristics of reentry could be readily induced in flecainide- treated
preparations either by increasing the stimulation rate or by introduction
of extrastimuli. Flecainide-induced slowing of conduction, more accentuated
at the faster stimulation rates, appeared to act synergistically with the
drug-induced dispersion of repolarization to generate reentry in these
relatively small sheets of epicardium. 4- Aminopyridine, a transient
outward current (Ito) blocker, reversed the flecainide-induced marked
abbreviation of APD in epicardium and abolished reentrant activity in all
cases. Flecainide failed to induce reentry in preparations pretreated with
4-aminopyridine. CONCLUSIONS. Our data suggest that the presence of a
prominent Ito in epicardium contributes the development of marked
electrical heterogeneity in the ventricle after exposure to flecainide.
Flecainide-induced dispersion of repolarization, especially when
accompanied by prominent conduction delays, results in extrasystolic
activity via a mechanism that we have termed "phase 2 reentry." Our results
also suggest a role for Ito blockers in the treatment of reentrant
arrhythmias.
ARTICLES
Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry?
Masonic Medical Research Laboratory, Utica, N.Y. 13504.
This article has been cited by other articles:
![]() |
A. S. Amin, E. A.A. de Groot, J. M. Ruijter, A. A.M. Wilde, and H. L. Tan Exercise-Induced ECG Changes in Brugada Syndrome Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 531 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ehrlich Arrhythmogenic Brugada syndrome substrate: a proof of principle Cardiovasc Res, March 1, 2009; 81(4): 635 - 636. [Full Text] [PDF] |
||||
![]() |
K. S. Stokoe, R. Balasubramaniam, C. A. Goddard, W. H. Colledge, A. A. Grace, and C. L.-H. Huang Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/ murine hearts modelling the Brugada syndrome J. Physiol., May 15, 2007; 581(1): 255 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Stokoe, G. Thomas, C. A. Goddard, W. H. Colledge, A. A. Grace, and C. L.-H. Huang Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/{Delta} murine hearts modelling long QT syndrome 3 J. Physiol., January 1, 2007; 578(1): 69 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Morita, D. P. Zipes, J. Lopshire, S. T. Morita, and J. Wu T wave alternans in an in vitro canine tissue model of Brugada syndrome Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H421 - H428. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aiba, W. Shimizu, I. Hidaka, K. Uemura, T. Noda, C. Zheng, A. Kamiya, M. Inagaki, M. Sugimachi, and K. Sunagawa Cellular Basis for Trigger and Maintenance of Ventricular Fibrillation in the Brugada Syndrome Model: High-Resolution Optical Mapping Study J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2074 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Patterson, R. Lazzara, B. Szabo, H. Liu, D. Tang, Y.-H. Li, B. J. Scherlag, and S. S. Po Sodium-Calcium Exchange Initiated by the Ca2+ Transient: An Arrhythmia Trigger Within Pulmonary Veins J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1196 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haghjoo, A. Arya, Z. Emkanjoo, and M. A. Sadr-Ameli Clinical and Electrophysiologic Profile of Brugada Syndrome in Iranian Patients Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 241 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Meregalli, A. A.M. Wilde, and H. L. Tan Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more? Cardiovasc Res, August 15, 2005; 67(3): 367 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon Pharmacology of cardiac potassium channels Cardiovasc Res, April 1, 2004; 62(1): 9 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Akar, R. C. Wu, I. Deschenes, A. A. Armoundas, V. Piacentino III, S. R. Houser, and G. F. Tomaselli Phenotypic differences in transient outward K+ current of human and canine ventricular myocytes: insights into molecular composition of ventricular Ito Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H602 - H609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kimura, T. Kobayashi, S. Owada, K. Ashikaga, T. Higuma, S. Sasaki, A. Iwasa, S. Motomura, and K. Okumura Mechanism of ST Elevation and Ventricular Arrhythmias in an Experimental Brugada Syndrome Model Circulation, January 6, 2004; 109(1): 125 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Pitzalis, M. Anaclerio, M. Iacoviello, C. Forleo, P. Guida, R. Troccoli, F. Massari, F. Mastropasqua, S. Sorrentino, A. Manghisi, et al. QT-interval prolongation inright precordial leads: an additional electrocardiographic hallmark of Brugada syndrome J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1632 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, J. A. Towbin, and K. Nademanee Brugada syndrome: 1992-2002: A historical perspective J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1665 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyoshi, H. Mitamura, K. Fujikura, Y. Fukuda, K. Tanimoto, Y. Hagiwara, M. Ita, and S. Ogawa A mathematical model of phase 2 reentry: role of L-type Ca current Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1285 - H1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, W. Shimizu, I. Gussak, and A.R. Perez Riera Brugada Syndrome: A Decade of Progress Circ. Res., December 13, 2002; 91(12): 1114 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Noda, W. Shimizu, A. Taguchi, K. Satomi, K. Suyama, T. Kurita, N. Aihara, and S. Kamakura ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1841 - 1847. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Di Diego, J. M. Cordeiro, R. J. Goodrow, J. M. Fish, A. C. Zygmunt, G. J. Perez, F. S. Scornik, and C. Antzelevitch Ionic and Cellular Basis for the Predominance of the Brugada Syndrome Phenotype in Males Circulation, October 8, 2002; 106(15): 2004 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurita, W. Shimizu, M. Inagaki, K. Suyama, A. Taguchi, K. Satomi, N. Aihara, S. Kamakura, J. Kobayashi, and Y. Kosakai The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome J. Am. Coll. Cardiol., July 17, 2002; 40(2): 330 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Roden The problem, challenge and opportunity of genetic heterogeneity in monogenic diseases predisposing to sudden death J. Am. Coll. Cardiol., July 17, 2002; 40(2): 357 - 359. [Full Text] [PDF] |
||||
![]() |
A.A.M. Wilde, C.A. Remme, R. Derksen, E.F.D. Wever, and R.N.W. Hauer Brugada syndrome Eur. Heart J., April 2, 2002; 23(8): 675 - 676. [Full Text] [PDF] |
||||
![]() |
J. R. Balser Inherited sodium channelopathies: models for acquired arrhythmias? Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1175 - H1180. [Full Text] [PDF] |
||||
![]() |
K. Shivkumar and J. N Weiss Atrial fibrillation: from cells to computers Cardiovasc Res, November 1, 2001; 52(2): 171 - 173. [Full Text] [PDF] |
||||
![]() |
M Takagi, N Aihara, S Kuribayashi, A Taguchi, W Shimizu, T Kurita, K Suyama, S Kamakura, S Hamada, and M Takamiya Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome Eur. Heart J., June 2, 2001; 22(12): 1032 - 1041. [Abstract] [PDF] |
||||
![]() |
D. M. Roden Pharmacogenetics and drug-induced arrhythmias Cardiovasc Res, May 1, 2001; 50(2): 224 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Antzelevitch The Brugada syndrome: diagnostic criteria and cellular mechanisms Eur. Heart J., March 1, 2001; 22(5): 356 - 363. [PDF] |
||||
![]() |
D. J. Huelsing, A. E. Pollard, and K. W. Spitzer Transient outward current modulates discontinuous conduction in rabbit ventricular cell pairs Cardiovasc Res, March 1, 2001; 49(4): 779 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Corrado, C. Basso, G. Buja, A. Nava, L. Rossi, and G. Thiene Right Bundle Branch Block, Right Precordial ST-Segment Elevation, and Sudden Death in Young People Circulation, February 6, 2001; 103(5): 710 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R Bezzina, M. B Rook, and A. A.M Wilde Cardiac sodium channel and inherited arrhythmia syndromes Cardiovasc Res, February 1, 2001; 49(2): 257 - 271. [Full Text] [PDF] |
||||
![]() |
M. W. Veldkamp, P. C. Viswanathan, C. Bezzina, A. Baartscheer, A. A. M. Wilde, and J. R. Balser Two Distinct Congenital Arrhythmias Evoked by a Multidysfunctional Na+ Channel Circ. Res., May 12, 2000; 86 (9): e91 - e97. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Benhorin, R. Taub, M. Goldmit, B. Kerem, R. S. Kass, I. Windman, and A. Medina Effects of Flecainide in Patients With New SCN5A Mutation : Mutation-Specific Therapy for Long-QT Syndrome? Circulation, April 11, 2000; 101(14): 1698 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Rook, C. Bezzina Alshinawi, W.A. Groenewegen, I. C. van Gelder, A. C.G. van Ginneken, H. J. Jongsma, M. M.A.M. Mannens, and A. A.M. Wilde Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome Cardiovasc Res, December 1, 1999; 44(3): 507 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dumaine, J. A. Towbin, P. Brugada, M. Vatta, D. V. Nesterenko, V. V. Nesterenko, J. Brugada, R. Brugada, and C. Antzelevitch Ionic Mechanisms Responsible for the Electrocardiographic Phenotype of the Brugada Syndrome Are Temperature Dependent Circ. Res., October 29, 1999; 85(9): 803 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Balser Sodium "Channelopathies" and Sudden Death : Must You Be So Sensitive? Circ. Res., October 29, 1999; 85(9): 872 - 874. [Full Text] [PDF] |
||||
![]() |
G.-X. Yan and C. Antzelevitch Cellular Basis for the Brugada Syndrome and Other Mechanisms of Arrhythmogenesis Associated With ST-Segment Elevation Circulation, October 12, 1999; 100(15): 1660 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tachibana, M. Yamaki, I. Kubota, T. Watanabe, S. Yamauchi, and H. Tomoike Intracoronary Flecainide Induces ST Alternans and Reentrant Arrhythmia on Intact Canine Heart : A Role of 4-Aminopyridine–Sensitive Current Circulation, March 30, 1999; 99(12): 1637 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alings and A. Wilde "Brugada" Syndrome : Clinical Data and Suggested Pathophysiological Mechanism Circulation, February 9, 1999; 99(5): 666 - 673. [Full Text] [PDF] |
||||
![]() |
E. Robert, A. G. M. Aya, J. E. de la Coussaye, P. Peray, J.-M. Juan, J. Brugada, J.-M. Davy, and J.-J. Eledjam Dispersion-based reentry: mechanism of initiation of ventricular tachycardia in isolated rabbit hearts Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H413 - H423. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gussak, C. Antzelevitch, P. Bjerregaard, J. A. Towbin, and B. R. Chaitman The Brugada syndrome: clinical, electrophysiologic and genetic aspects J. Am. Coll. Cardiol., January 1, 1999; 33(1): 5 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brugada, P. Brugada, and R. Brugada The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death--the Brugada syndrome Europace, January 1, 1999; 1(3): 156 - 166. [Abstract] [PDF] |
||||
![]() |
G.-R. Li, J. Feng, L. Yue, and M. Carrier Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H369 - H377. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nattel Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs Cardiovasc Res, March 1, 1998; 37(3): 567 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gotoh, T. Uchida, W. J. Mandel, M. C. Fishbein, P.-S. Chen, and H. S. Karagueuzian Cellular Graded Responses and Ventricular Vulnerability to Reentry by a Premature Stimulus in Isolated Canine Ventricle Circulation, April 15, 1997; 95(8): 2141 - 2154. [Abstract] [Full Text] |
||||
![]() |
E. P. Anyukhovsky, E. A. Sosunov, and M. R. Rosen Electrophysiologic Effects of Nibentan (HE-11) on Canine Cardiac Tissue J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1137 - 1146. [Abstract] [Full Text] |
||||
![]() |
A. Lukas Electrophysiology of Myocardial Cells in the Epicardial, Midmyocardial, and Endocardial Layers of the Ventricle Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(1): 61 - 72. [Abstract] [PDF] |
||||
![]() |
G.-X. Yan and C. Antzelevitch Cellular Basis for the Electrocardiographic J Wave Circulation, January 15, 1996; 93(2): 372 - 379. [Abstract] [Full Text] |
||||
![]() |
M. Nabauer, D. J. Beuckelmann, P. Uberfuhr, and G. Steinbeck Regional Differences in Current Density and Rate-Dependent Properties of the Transient Outward Current in Subepicardial and Subendocardial Myocytes of Human Left Ventricle Circulation, January 1, 1996; 93(1): 168 - 177. [Abstract] [Full Text] |
||||
![]() |
M. R. Ujhelyi, M. Schur, T. Frede, M. Gabel, and M. L. Markel Differential Effects of Lidocaine on Defibrillation Threshold With Monophasic Versus Biphasic Shock Waveforms Circulation, September 15, 1995; 92(6): 1644 - 1650. [Abstract] [Full Text] |
||||
![]() |
J. Coromilas, A. E. Saltman, B. Waldecker, S. M. Dillon, and A. L. Wit Electrophysiological Effects of Flecainide on Anisotropic Conduction and Reentry in Infarcted Canine Hearts Circulation, April 15, 1995; 91(8): 2245 - 2263. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |